CTRI/2021/09/036832已完成未知
Evaluation for the risk of allergy to COVID-19 vaccines in people with history of allergy diathesis.
ICMR0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Participants with history of anaphylaxis or allergic reaction or any allergies.
- •Participants who are yet unvaccinated to COVID-19 vaccine OR Participants who have taken the first dose of COVID-19 vaccine, due for the second dose OR Participants who have taken second dose of COVID-19 vaccine, due for precautionary dose OR Participant who have history of allergic reaction to first and/or second dose of COVID-19 vaccine.(Any one of these criteria should be satisfied)
- •Participant of either gender of more than 18 years.
- •Participants who are able to provide a written informed consent or have a legally accepted representative [LAR] to provide the same.
排除标准
- •Participants who are participating in any other clinical trial or experimental treatment for COVID-19.
- •Participants who are not deemed fit as per the investigator or his/her team for any other medical reason.
- •Female participants who are pregnant or lactating.
研究者
相似试验
已完成
不适用
Evaluation of allergic reactions following COVID -19 vaccination in patients with documented allergiesCTRI/2021/09/036490ICMR227
已完成
Unknown
Cutaneous adverse events following the COVID-19 vaccination: a case series of 30 Japanese patients and a review of 93 Japanese studiesCutameous adverse events to COVID-19 vaccinationJPRN-UMIN000053107Kagoshima City Hospital30
已完成
不适用
To study if BCG vaccinated individuals have enhanced COVID-19 antibodies after COVID-19 vaccination.CTRI/2022/10/046542I70
招募中
不适用
Evaluation of COVID-19 antigen test in COVID-19 suspected casesCOVID-19JPRN-UMIN000040386agasaki University300
已完成
不适用
Serological response to COVID-19 and association with MR containing vaccineCTRI/2021/01/030363niversity College of Medical Sciences90